FedEx launches FedEx Life Sciences to support healthcare supply chains
Seeking Alpha ·
FedEx ( FDX ) has launched FedEx Life Sciences to handle the transportation of medical devices, pharmaceuticals, biologics, and clinical trial materials. The move advances the company's existing healthcare infrastructure, including its IATA CEIV Pharma Corporate Certification obtained in 2025. The logistics giant also recently
DYAX Investor Sentiment
Bullish (Long) 59% · Bearish (Short) 41%
269 participants
Related News
- Everyone Is Watching Greg Abel. But Another Berkshire Hathaway Stock Picker Is Quietly Winning in 2026.
- Pepsi Reported Higher Revenue and Earnings. So Why Is the High-Yield Dividend Stock Hovering Around a 52-Week Low?
- Air Liquide plans $200M expansion to boost production at Texas chemical site
- Micron Technology Is Quietly Setting Up for a Strong Earnings Catalyst
- Did Tesla’s Miami Robotaxi Launch and Q2 Numbers Just Shift TSLA’s Autonomy‑First Narrative?
- Amazon (AMZN) Launches Leo Broadband As Alexa Ads And AWS AI Reach Grow